Medicus Pharma Statistics
Total Valuation
Medicus Pharma has a market cap or net worth of $17.65 million. The enterprise value is $14.86 million.
| Market Cap | 17.65M |
| Enterprise Value | 14.86M |
Important Dates
The last earnings date was Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Medicus Pharma has 55.16 million shares outstanding. The number of shares has increased by 102.71% in one year.
| Current Share Class | 55.16M |
| Shares Outstanding | 55.16M |
| Shares Change (YoY) | +102.71% |
| Shares Change (QoQ) | +58.81% |
| Owned by Insiders (%) | 6.17% |
| Owned by Institutions (%) | 5.66% |
| Float | 48.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 10.19 |
| P/TBV Ratio | 14.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 1.77.
| Current Ratio | 1.22 |
| Quick Ratio | 1.07 |
| Debt / Equity | 1.77 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -50.89 |
Financial Efficiency
Return on equity (ROE) is -2,865.18% and return on invested capital (ROIC) is -568.20%.
| Return on Equity (ROE) | -2,865.18% |
| Return on Assets (ROA) | -278.12% |
| Return on Invested Capital (ROIC) | -568.20% |
| Return on Capital Employed (ROCE) | -1,976.28% |
| Weighted Average Cost of Capital (WACC) | 3.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.20M |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.69% in the last 52 weeks. The beta is -0.50, so Medicus Pharma's price volatility has been lower than the market average.
| Beta (5Y) | -0.50 |
| 52-Week Price Change | -87.69% |
| 50-Day Moving Average | 0.34 |
| 200-Day Moving Average | 1.36 |
| Relative Strength Index (RSI) | 46.30 |
| Average Volume (20 Days) | 1,981,668 |
Short Selling Information
The latest short interest is 2.98 million, so 5.41% of the outstanding shares have been sold short.
| Short Interest | 2.98M |
| Short Previous Month | 2.19M |
| Short % of Shares Out | 5.41% |
| Short % of Float | 6.11% |
| Short Ratio (days to cover) | 1.14 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -29.11M |
| Pretax Income | -51.22M |
| Net Income | -51.22M |
| EBITDA | n/a |
| EBIT | -29.11M |
| Earnings Per Share (EPS) | -$2.37 |
Balance Sheet
The company has $6.37 million in cash and $2.53 million in debt, with a net cash position of $3.83 million or $0.07 per share.
| Cash & Cash Equivalents | 6.37M |
| Total Debt | 2.53M |
| Net Cash | 3.83M |
| Net Cash Per Share | $0.07 |
| Equity (Book Value) | 1.43M |
| Book Value Per Share | 0.03 |
| Working Capital | 1.33M |
Cash Flow
| Operating Cash Flow | -27.81M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 1.29M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Medicus Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -102.71% |
| Shareholder Yield | -102.71% |
| Earnings Yield | -274.06% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for Medicus Pharma is $5.67, which is 1,671.88% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.67 |
| Price Target Difference | 1,671.88% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 25, 2024. It was a reverse split with a ratio of 1:2.
| Last Split Date | Oct 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |